| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424453000 | Telescoping two piece | 20 |
| 20080305159 | Ibuprofen-Hydrocodone-Antihistamine Composition - A pharmaceutical composition for use in relieving cold and cough symptoms in a mammal includes ibuprofen, hydrocodone bitartrate and an antihistamine (or a decongestant). The ibuprofen is in a therapeutically effective amount sufficient to act as an analgesic and an anti-inflammatory. The hydrocodone bitartrate is in a therapeutically effective amount sufficient to act as an antitussive and an analgesic. The antihistamine is in a therapeutically effective amount to act as an antihistamine. A fatty excipient may be added to the active ingredients to facilitate encapsulation. Multiple layers of the fatty excipient may be employed in varying release formulations and to facilitate identification of the composition. | 12-11-2008 |
| 20090074855 | ENTERIC COASTINGS FOR ORALLY INGESTIBLE COMPOSITIONS - A suspendible enteric coating composition for encasing orally ingestible articles wherein the enteric coating composition comprises a pH-dependent polymer selected from a group containing alginates and alginic acids, a pH-independent water insoluble polymer selected from the group comprising ethylcellulose and ethylcellulose-containing compositions, and a plasticizer selected from the group containing triethyl citrate, glycerin, propylene glycol, triacetin, acetylated monoglycerides, dibutyl sebacate, polyethylene glycols, sorbitals, middle chain triglycerides and combinations thereof. A three step method for providing a stable outer enteric coating on an ingestable item comprising a first step of encasing the item with a suspension comprising a mixture of at least a sugar and a microcrystalline cellulose, a second step of then encasing the item with a suspension comprising a mixture of a film-forming polymer and a plasticizer, and a third step of finally encasing the item with the enteric coating composition. | 03-19-2009 |
| 20090162430 | Gelatin Capsule With Extra Cap for Combined Therapies - A new pharmaceutical dosage form for the administration of combined therapies without interaction between them is disclosed. It consists of an upper gelatin capsule, hard or soft, with extra lower hard gelatin cap. The upper capsule contains one or more biologically active agent and the lower hard gelatin cap contains other biologically active agent or agents. Other lower or upper caps could be added to said capsule containing other biologically active agents with the same principle. | 06-25-2009 |
| 20100285116 | PHYSICALLY/MOLECULARLY DISTRIBUTED AND/OR CHEMICALLY BOUND MEDICAMENTS IN EMPTY, HARD CAPSULE SHELLS - The present invention incorporates medicaments in the empty hard capsule shells (body and cap). The medicament is either physically/molecularly distributed and/or chemically bound to the polymer matrix of the capsule shell composition. Other medicaments in the form of drug-loaded matrices (powders, granules, beads, pellets, mini-tablets, and mini-capsules) can be filled in the drug-loaded empty, hard capsule shells. The same capsule dosage form contains medicaments in the core matrix and in the shell. | 11-11-2010 |
| 20110171298 | HARD CAPSULE COMPOSITION AND METHOD OF USE - A method for making a clear hard vegetarian gelatin free two piece capsule by creating a first phase network system using a seaweed extract, a galactomannan extract and a rheology modifier. A filler is created for the first phase network by blending a water, a crystalline alcohol, a polysaccharide, and a sugar alcohol at a temperature less than 80 Fahrenheit. The filler is then mixed into the first phase network system forming a biphasic system. Capsules are then formed by dipping conventional moulding pins into the biphasic solution, blowing hot air on the dipped pins in a chamber with a humidity that is no more than 25 percent, blowing away water on the outer surface of the dipped pins to bond and lock moisture to the polysaccharide and removing the capsule pieces from the pins. The two piece capsule has an outer surface which is mechanically and dimensionally stable. | 07-14-2011 |
| 20130011469 | KRILL OIL AND CAROTENOID COMPOSITION, ASSOCIATED METHOD AND DELIVERY SYSTEM - A medicine delivery system includes an inner capsule containing carotenoids and an outer capsule in which the inner capsule is contained within the outer capsule and the outer capsule containing a therapeutically effective amount of krill oil. In one example, the carotenoids comprise at least S, S′-astaxanthin derived from | 01-10-2013 |
| 20130295171 | KRILL OIL AND REACTED ASTAXANTHIN COMPOSITION AND ASSOCIATED METHOD - A method of enhancing cardiovascular health includes administering a therapeutic amount of a composition comprising krill oil reacted with astaxanthin. A medicine delivery system for the method and composition includes an inner capsule containing carotenoids and an outer capsule in which the inner capsule is contained within the outer capsule and the outer capsule containing a therapeutically effective amount of krill oil. In one example, the carotenoids comprise at least S, S′-astaxanthin derived from | 11-07-2013 |
| 20140302133 | CAPSULE WITH INTERNAL DIAPHRAGM - A capsule of, for instance, hard gelatin for holding a substance such as medicine, food supplements or similar materials includes a capsule body having a closed and an opposed open end with a predetermined length defined between the ends. A diaphragm having a closed end and an opposed open end and a predetermined length there between seals off the body and provides a first compartment to hold a first medicine, food supplement, etc. A cap is applied to the body as is conventional in capsules. The space between the inner portion of the cap and the diaphragm defines a second compartment for holding a second medicine, food supplement, etc. The contents of each compartment may be wet or dry (e.g., powder or liquid.) This two-compartment capsule has particular relationships between the length along an axis of the capsule of the diaphragm to that of the body, and particular dimensional parameters relating to the sidewall contact seal between the outer portion of the diaphragm and the inner wall of the body, to provide adequate capsule sealing and stability during and after manufacture. | 10-09-2014 |
| 20140328909 | KRILL OIL AND REACTED ASTAXANTHIN COMPOSITION AND ASSOCIATED METHOD - A method of treating and alleviating joint pain includes administering a therapeutic amount of a composition comprising krill oil reacted with astaxanthin. A medicine delivery system for the method and composition includes an inner capsule containing carotenoids and an outer capsule in which the inner capsule is contained within the outer capsule and the outer capsule containing a therapeutically effective amount of krill oil. In one example, the carotenoids comprise at least S, S′-astaxanthin derived from | 11-06-2014 |
| 20150024043 | Medi-Cap (Bio-Absorbable Capsules) - Medi-Cap a specialized absorbable capsule of various shapes and sizes. It may come prefilled with desired medication or material or it can come in a two-piece snap together capsule that can be filled with desired medication/material by the medical professional. (Most Likely prefilled) Medi-Cap will be time released meaning that each capsule used in an area of treatment will have a specific time in which the capsule will degrade and release the medication in the area of operation or treatment. Depending on what Medi-Cap will be used for there should be different capsules with different absorbing times. | 01-22-2015 |
| 20150328164 | PHYSICALLY DISPERSED, MOLECULARLY DISSOLVED AND/OR CHEMICALLY BOUND DRUG(S) IN AN EMPTY, HARD CAPSULE SHELL COMPOSITION - The present invention proposes a design to incorporate drug(s) in the hard capsule shells (body and cap) composition. Drug(s) in the cap and body of the capsule shell may be the same or may be different. Other drug(s) in the form of granules, beads etc. can be filled into the capsules as a core material. The drug(s) in the capsule core material may be the same as in the shell-composition or may be different. Thus, the same capsule may contain different drug(s) as the core material and in the shell. The key advantages of incorporation of drug in the capsule shell compositions are to minimize drug-drug interaction and to obtain a desired rate of release of the drug(s), mainly for potent ones. The concept can be applied to the hard gelatin, and hard non-gelatin capsules. | 11-19-2015 |
| 20160184370 | Compositions and Methods - Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health. | 06-30-2016 |
| 20180021286 | STABILIZED DIALKYL FUMARATE COMPOSITIONS | 01-25-2018 |
| 424454000 | With tamperproof, locking, or sealing feature | 7 |
| 20080254111 | Bandseal for peg-filled hard capsule - The present invention provides a band seal for hard capsules filled with PEG, particularly a low-molecular-weight PEG, PEG | 10-16-2008 |
| 20090110723 | Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms - A linker for multicomponent dosage form has a preformed drug substance tablet and an injection molded jacket including one or both axial jacket ends open for dispensing the preformed drug substances. The jacket has snap-fit connection elements on the outer surface adjacent each end for engagement with complementary snap-fit element on capsule-type and cap-type dosage form units. Another multicomponent drug form linker is injection molded with a raised circumferential band and snap-fit elements between the band and respective ends engageable with complementary snap-fit elements on dosage form units to provide compressive abutting contact between ends of the units and the band. The band can have an axially tapered outer surface to accommodate dosage form units of different diameters. Still another multicomponent dosage form linker has separable male and female parts each engageable with, and separately sealing, respective dosage form units to be linked. Circumferential complementary grooves, groove segments, ridges and ridge segment-type snap-fit elements are disclosed, as are dosage forms using the above-described linkers. | 04-30-2009 |
| 20100119597 | MULTI-COMPONENT PHARMACEUTICAL DOSAGE FORM - A multi-component pharmaceutical dosage form comprising a plurality of drug substance—containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form. | 05-13-2010 |
| 20110064802 | IMPROVED CAPSULE WITH AIR-VENTS - The invention relates to a capsule comprising a hollow tubular body ( | 03-17-2011 |
| 20110097397 | BREAK RESISTANT GEL CAPSULE - A gelatin capsule is disclosed that is designed to impart less tensile stress on the component parts when it is in the closed position and experiences less spontaneous breakage particularly when fill with hygroscopic liquids. The gelatin capsule comprises a cap portion and a body portion. The cap portion includes an annular ring and the body portion includes an annular groove. Together, the annular ring and the annular groove comprise a locking ring, which are designed to reduce the capsule cap and body contact force and stress raisers. The invention includes a cap locking ring inner diameter that is same as body locking ring outer diameter or slightly smaller to make the contacting force at the locking ring lower than current capsule designs. The body portion also includes a tapered ring configured such that, in the closed position the rim of the body portion does not contact the cap portion. | 04-28-2011 |
| 20120263787 | METHOD AND APPARATUS FOR SEALING MEDICINAL CAPSULES - A method of sealing parts of a plastic capsule by forming a weld seam in an overlapping region of the parts of the capsule, wherein the capsule comprises a capsule cap having an open end and a capsule body having an open end, and capsules formed by such method. The capsules produced by the process according to the invention are disposable and preferably contain a single dose of a pharmaceutical formulation in the form of a powder or liquid intended to be administered by inhalation and are suitable by their form and function for use in powder inhalers or liquid nebulizers for producing aerosols. Aerosols thus produced can be inhaled, for example, in order to administer a pharmaceutical formulation to the lungs. | 10-18-2012 |
| 20160022593 | SEPARABLE CAPSULE - The present disclosure relates to a separable hard capsule for containing a medication. The capsule may be opened by finger force and used, for example, by pediatric and geriatric patients. | 01-28-2016 |
